Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DIG
ProShares Ultra Energy
$33.68
-1.0%
$32.45
$26.50
$47.04
$75.78M1.5266,058 shs65,731 shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$30.25
+0.1%
$28.67
$23.69
$31.72
$13.25B0.68817,601 shs882,877 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DIG
ProShares Ultra Energy
0.00%-7.24%+9.89%-20.17%-20.21%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.00%+5.02%+4.44%+6.55%+22.05%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
DIG
ProShares Ultra Energy
N/AN/AN/AN/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
3.6742 of 5 stars
1.05.02.50.03.30.04.4
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DIG
ProShares Ultra Energy
2.61
Moderate Buy$33.68N/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.00
Hold$28.00-7.42% Downside

Current Analyst Ratings Breakdown

Latest DIG, WWH, BHMU, and SNN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2025
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$27.00 ➝ $28.00
4/25/2025
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/25/2025
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DIG
ProShares Ultra Energy
N/AN/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$5.81B2.28$3.16 per share9.57$12.04 per share2.51
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DIG
ProShares Ultra Energy
N/AN/A14.85N/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$412M$2.1614.0015.120.93N/AN/AN/A8/5/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
DIG
ProShares Ultra Energy
$1.043.09%N/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.892.94%N/A41.20%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DIG
ProShares Ultra Energy
N/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.62
2.89
1.33

Institutional Ownership

CompanyInstitutional Ownership
DIG
ProShares Ultra Energy
N/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
25.64%

Insider Ownership

CompanyInsider Ownership
DIG
ProShares Ultra Energy
N/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
DIG
ProShares Ultra Energy
N/A2.25 millionN/ANot Optionable
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
17,349437.97 million433.59 millionOptionable

Recent News About These Companies

Smith & Nephew (SN) Receives a Buy from Citi

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

ProShares Ultra Energy NYSEARCA:DIG

$33.68 -0.34 (-1.00%)
As of 06/27/2025 04:10 PM Eastern

ProShares Ultra Oil & Gas (the fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Oil & Gas Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund.

Smith & Nephew SNATS stock logo

Smith & Nephew SNATS NYSE:SNN

$30.24 +0.04 (+0.12%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$30.22 -0.03 (-0.08%)
As of 06/27/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.